Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
Noosa News24 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General13 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General23 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General20 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank